VAUGHN SMIDER Insider Trading $ELOX Eloxx Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VAUGHN SMIDER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VAUGHN SMIDER. VAUGHN SMIDER is Chief Scientific Officer in Sevion Therapeutics, Inc. ($SVON).
VAUGHN SMIDER in Eloxx Pharmaceuticals, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of VAUGHN SMIDER: Chief Scientific Officer
Holdings: 1,058,970 shares
Current Value: $243,563
Latest Transaction: May 20 2014
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of VAUGHN SMIDER in Eloxx Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 2.00 | 410 | 820 | 13,804 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 2.00 | 23 | 46 | 762 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 4.00 | 8,185 | 32,740 | 276,047 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 4.00 | 244 | 976 | 8,180 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 3.00 | 7,411 | 22,233 | 249,974 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 2.00 | 13,394 | 26,788 | 13,394 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 2.00 | 739 | 1,478 | 739 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 4.00 | 267,862 | 1,071,448 | 267,862 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 4.00 | 7,936 | 31,744 | 7,936 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 3.00 | 242,563 | 727,689 | 242,563 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Grant | A | 0.00 | 31,396 | 0 | 1,058,970 | 1 M to 1.1 M (+3.06 %) |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Grant | A | 0.00 | 1,027,574 | 0 | 1,058,970 | 31.4 K to 1.1 M (+3,272.95 %) |
Page: 1